Biological effects of pulsating magnetic fields: role of solitons

In this paper, we analyze biological effects produced by magnetic fields in order to elucidate the physical mechanisms, which can produce them. We show that there is a chierarchy of such mechanisms and that the mutual interplay between them can result in the synergetic outcome. In particular, we analyze the biological effects of magnetic fields on soliton mediated charge transport in the redox processes in living organisms. Such solitons are described by nonlinear systems of equations and represent electrons that are self-trapped in alpha-helical polypeptides due to the moderately strong electron-lattice interaction. They represent a particular type of disssipativeless large polarons in low-dimensional systems. We show that the effective mass of solitons in the is different from the mass of free electrons, and that there is a resonant effect of the magnetic fields on the dynamics of solitons, and, hence, on charge transport that accompanies photosynthesis and respiration. These effects can result in non-thermal resonant effects of magnetic fields on redox processes in particular, and on the metabolism of the organism in general. This can explain physical mechanisms of therapies based on applying magnetic fields.

💡 Research Summary

The paper investigates how pulsating magnetic fields (PMFs) can influence biological processes through a non‑thermal, resonant interaction with soliton‑mediated charge transport in living organisms. The authors begin by outlining a hierarchy of magnetic‑field mechanisms: (1) direct electromagnetic effects that act on ion channels, membrane potentials, and other classic electrophysiological targets, and (2) indirect, non‑linear mechanisms that arise in low‑dimensional biological structures. The latter category includes solitons—self‑trapped electrons that travel along α‑helical polypeptide chains because of a moderate electron‑lattice coupling. In this context, a soliton is a dissipation‑less large polaron, whose effective mass (m* ≈ (1 + γ)mₑ) differs markedly from that of a free electron due to the added lattice inertia.

The authors model the electron‑lattice system with a nonlinear Schrödinger equation coupled to a continuum description of the peptide backbone. When a time‑varying magnetic vector potential A(t) = A₀ sin(ωt) is introduced, minimal coupling adds a phase term φ = (e/ħ)∫A·dl to the soliton wavefunction. This phase modulates the soliton’s velocity v = v₀ cos Δφ, where Δφ = (e/ħ)A₀ d sin(ωt) and d is the inter‑residue spacing (≈ 3.6 Å). Consequently, if the driving frequency ω matches the soliton’s intrinsic frequency ω₀, a resonant condition emerges: charge transport can be dramatically enhanced or suppressed without any accompanying temperature rise. The resonance is purely quantum‑mechanical, reflecting the soliton’s non‑linear dynamics rather than classical heating.

From a biological perspective, the authors focus on two major energy‑conversion pathways: photosynthetic electron transport in photosystem II and mitochondrial respiration. Both systems contain protein complexes rich in α‑helices (e.g., the reaction center, cytochrome bc₁ complex). In these complexes, electrons are believed to propagate as solitons rather than as free carriers. When a PMF is tuned to the soliton resonance, the rate of electron transfer between redox centers changes, altering the overall efficiency of ATP synthesis. For example, a resonant PMF can increase the NADH oxidation rate in complex I, thereby boosting the proton motive force and ATP production. Conversely, off‑resonance fields may slow electron flow, potentially leading to a controlled reduction in metabolic rate.

The therapeutic implications are explored through the lens of low‑frequency pulsed magnetic field (LF‑PMF) therapy, which typically employs frequencies between 10 Hz and 100 Hz and magnetic flux densities of 0.1–10 mT. The authors argue that these parameters can be selected to approximate the soliton resonance condition for specific biological targets. Under such conditions, the magnetic field can non‑thermally modulate redox balance, promote ATP regeneration, and accelerate tissue repair in inflamed or damaged regions. Because solitons are essentially loss‑free carriers, the energy cost of sustained PMF exposure is minimal, and side‑effects are expected to be low.

To validate the theory, the paper proposes experimental strategies: (i) in‑vitro measurements of electron transport using ultrafast spectroscopy while applying controlled PMFs, (ii) monitoring soliton velocity changes via time‑resolved conductivity assays, and (iii) assessing metabolic markers (e.g., NAD⁺/NADH ratios, ATP levels) in cell cultures and animal models before and after LF‑PMF treatment. Metabolomic profiling would reveal whether the predicted non‑thermal shifts in redox state occur in vivo.

In summary, the study presents a coherent physical mechanism whereby pulsating magnetic fields can resonantly interact with soliton‑based charge carriers in α‑helical proteins, leading to non‑thermal modulation of redox reactions and metabolic activity. This mechanism bridges the gap between classical electromagnetic biology and quantum‑nonlinear dynamics, offering a solid theoretical foundation for magnetic‑field‑based therapeutic modalities and guiding future experimental investigations into low‑frequency magnetic field applications.